摘要:目的:探討胺碘酮治療充血性心力衰竭(CHF)心房顫動(dòng)伴快速心室率的臨床療效。方法: 將106例各種原因所致的房顫伴快速心室率的CHF患者按入院順序隨機(jī)分為治療組及對照組。兩組抗CHF基礎(chǔ)治療相同,治療組加用靜脈負(fù)荷量胺碘酮150 mg后,再以1 000μg/min靜脈點(diǎn)滴維持6小時(shí),500 μg/min靜滴18小時(shí)。同時(shí)口服胺碘酮0.2,3次/d,1周;再0.2,2次/d,1周以后以0.2,1次/d 至觀察終點(diǎn),隨診為12個(gè)月。 結(jié)果: 治療組53例使用胺碘酮治療可顯著增加抗心律失常有效性,改善左室射血分?jǐn)?shù),減少心力衰竭再住院率,42例患者轉(zhuǎn)復(fù)為室性心律。 結(jié)論: 靜脈及口服胺碘酮同時(shí)應(yīng)用治療充血性心力衰竭房顫是有效和安全的。Abstract: Objective: To explore the effect and safety of amiodarone in the treatment of atrial fibrillation with congestive heart failure. Methods:One hundred and six patients of AF with CHF caused by a variety of reasons were randomly divided into treatment group and control group according to hospitalized order.The two groups were treated with the same antiCHF therapy,the treatment group was treated with loaded intravenous amiodarone 150 mg;and then dripped to 1 000 μg/min for 6 hours, dripped to 500 μg/min for 18 hours. United with oral amiodarone by amiodarone tablets with 0.2 g,3 time/day a week,further 0.2 g,2 times/day a week,later 0.2 g,1 times/day to the end.The end of followup time was 12 months. Results:In treatment group,53 cases with amiodarone therapy can significantly increase the effectives of antiarrhythmic, improve the rate and heart failure rehospitalization.42/53 patients reversed to sinus rhythm. Conclusion:The results showed it is effective and safe united with intravenous amiodarone and oral amiodarone in treatment of atrial fibrillation with organic heart disease.